The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarget Healthc. Regulatory News (THRL)

Share Price Information for Target Healthc. (THRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 79.80
Bid: 79.80
Ask: 80.20
Change: -0.30 (-0.37%)
Spread: 0.40 (0.501%)
Open: 80.40
High: 81.00
Low: 79.10
Prev. Close: 80.10
THRL Live PriceLast checked at -
Target Healthcare REIT is an Investment Trust

To provide ordinary shareholders with an attractive level of income with the potential for capital and income growth from investing in best-in-class care home assets with attractive financial characteristics.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Corporate Update, Net Asset Value & Dividend

27 Oct 2016 07:00

RNS Number : 5608N
Target Healthcare REIT Limited
27 October 2016
 

27 October 2016

 

Corporate Update, Net Asset Value & Dividend announcement

 

Net Asset Value

 

Target Healthcare REIT Limited (the "Company" and together with its subsidiaries, the "Group") announces that its unaudited EPRA NAV per share as at 30 September 2016 was 100.0 pence. The EPRA NAV total return for the quarter was 1.0%.

 

 

Corporate Update

 

Portfolio

 

As at 30 September 2016 the Group owned forty care homes with a market value of £232.3 million. The valuation of the homes is based on the independent external valuation of the Group's property portfolio prepared by Colliers International Healthcare LLP ("Colliers"). Colliers has updated the clause contained in its valuation relating to the UK's decision to leave the EU, stating that after an initial period of uncertainty and an absence of activity, transactional volumes and available evidence has risen in most sectors of the market and liquidity is returning to more normal levels. Colliers further state that this has led to a generally more stable outlook for the market.

 

On a like-for-like basis the portfolio has increased in value by 0.5% over the quarter. The increase reflects an element of yield compression across individual assets as the underlying trading performance of the homes mature as well as uplifts from six rent reviews where rents increased by an average of 2.4%, resulting in a like-for-like increase to portfolio passing rent of 0.3%.

 

As at 30 September 2016, the portfolio had an EPRA net initial yield of 6.9% (based on contractual net income) and an annualised rent roll of £16.9 million with a weighted average unexpired lease term of 29.1 years.

 

A balance sheet summary and an analysis of the movement in EPRA NAV over the quarter is presented in the Appendix.

 

Debt facilities: Extension, renegotiation & swap arrangements

 

On 1 September 2016 the Group extended the term of its £50 million facility with RBS from June 2019 to September 2021, and renegotiated interest to be payable at a rate equal to 3 month LIBOR plus a margin of 1.5% per annum, a reduction of 50 bps from the previous margin of 2.0% per annum.

 

In addition, the amendment provides an option of two further one year extensions thereafter, subject to the consent of RBS. 

 

The Group's total borrowings were £21.0 million at 30 September 2016, giving a loan-to-value ratio of 9.0% (calculated as total gross debt as a proportion of gross property value). As the Group expects to invest the vast majority of its current cash balance in new care homes, cash has been excluded from the calculation.

 

The Group's interest rate swap arrangements provide an all-in interest cost on the £21.0 million of currently drawn debt of 2.35% for the period to 24 June 2019 and 2.20% thereafter until 1 September 2021.

 

The Group has total agreed facilities of £50 million allowing it to draw down a further £29 million. The debt availability will allow the Group to manage its capital structure in line with its stated intention that over the medium term the average loan-to-value ratio will be approximately 20%, whilst also providing shorter term capital to fund the completion of transactions.

 

Pipeline and Investment Market

 

In the three months to 30 September 2016, the Group has invested £20.5 million in new acquisitions, inclusive of acquisition costs, as follows:

 

· £14.0 million in two modern, purpose built care homes located in Dundee, Scotland and Sandiacre, Derbyshire. The homes will continue to be operated by the incumbent operator, Hudson Healthcare who became the 14th tenant of the Group, thereby further diversifying the Group's tenant base. The homes are subject to 35-year leases with RPI-linked cap and collar.

 

· £6.5 million a modern, purpose built care home in Mytchett near Camberley, Surrey. Upon acquisition, the home was leased back to the existing tenant, Care Concern Group, who has operated the home since its opening. The lease is for a term of 35-years and is subject to an RPI-linked cap and collar.

 

Subsequent to 30 September 2016, the Group has completed the following acquisition:

 

· A purpose built care home in Tonbridge, Kent for approximately £12.2 million including acquisition costs. The Group had previously entered into a forward commitment to acquire this property. The home is let to Abbeyfield Kent Society, a charitable organisation which provides care and housing to over 400 people at 14 locations across Kent. The lease is for a 30 year term with RPI-linked uplifts subject to a cap and collar. Abbeyfield is the Group's 15th tenant and further diversifies the Group's tenant base.

 

Additionally, the Group has completed renovation works at its home in Sheffield which is expected to open to new residents in the coming days.

 

Since the Company's £84 million capital raise in April, the Group has committed to investments of £70 million. In addition the Group has near-term investment opportunities of £23 million, of which it hopes to complete or commit to the majority following diligence processes. The Investment Manager continues to identify a wider pipeline of assets where the timetable for potential completion remains uncertain pending due diligence and vendor negotiations.

 

Dividends in the period

 

The Company paid its fourth interim dividend for the year to 30 June 2016, in respect of the period from 1 April 2016 to 30 June 2016, of 1.545 pence per share on 26 August 2016. This reflects an annualised payment of 6.18 pence per share and a dividend yield of 5.6% based on the 26 October 2016 closing share price of 110.75 pence.

 

The Group's unaudited EPRA Earnings per share for the quarter were 1.1 pence, excluding the effects of accrual for potential performance fee for the year to 31 December 2016 as noted in the Appendix.

 

The Company had 252,180,851 ordinary shares in issue at 30 September 2016 and has not issued or bought back any shares since that date.

 

 

Announcement of First Interim Dividend for the year ending 30 June 2017

 

The Company has today declared its first interim dividend payment for the year ending 30 June 2017, in respect of the period from 1 July 2016 to 30 September 2016 of 1.570 pence per share as detailed in the schedule below:

 

Interim Property Income Distribution (PID) 1.256 pence per share

Interim Ordinary Dividend 0.314 pence per share

 

Ex-Dividend Date: 3 November 2016

Record Date: 4 November 2016

Pay Date: 25 November 2016

 

 

 

Quarterly investor report

 

The Group's quarterly investor report for September 2016 will shortly be available on its website at:

 

 http://www.targethealthcarereit.co.uk/Financial%20reporting.aspx

 

Kenneth MacKenzie, Managing Partner of Target Advisers LLP, commented on the Group's activity during the period:

 

"We remain focussed on the continued investment of capital provided by shareholders which have passed our unique and rigorous investment appraisal process. We are particularly pleased with the recent acquisition of two high quality properties which will be accretive to the portfolio. Both of these properties were unfinished at the time of the Group's commitment, allowing us to maximise our asset management skills in creating high quality purpose built homes. The Group also benefits from the additional security of both properties being fully pre-let with the security of long-term leases set at sustainable rental levels."

 

Enquiries:

 

Kenneth MacKenzie

Target Advisers

01786 845 912

 

Stifel Nicolaus Europe Limited

Mark Young, Neil Winward, Tom Yeadon

020 7710 7600

 

Martin Cassels

R&H Fund Services Limited

0131 550 3760

 

Fiona Harris/Sam Emery

Quill PR

020 7466 5058 / 020 7466 5056

 

 

Important information

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

 

 

APPENDIX

 

Analysis of movement in EPRA NAV

 

The following table provides an analysis of the movement in the unaudited EPRA NAV per share for the period from 1 July 2016 to 30 September 2016:

 

 

Pence per share

 

EPRA NAV per share as at 30 June 2016

100.6

 

 

Property revaluation

 

0.3

 

Property acquisition costs

(0.3)

 

Movement in revenue reserve (excluding performance fee accrual for year to 31 December 2016)

1.0

 

Movement in performance fee accrual*

(0.1)

 

Fourth interim dividend payment for the year to 30 June 2016

(1.5)

 

EPRA NAV per share as at 30 September 2016

100.0

 

Percentage change in the 3 month period

(0.6%)

 

 

*An accrual for a performance fee, if due, for the year from 1 January 2016 to 31 December 2016, payable to the investment manager. The accrued amount is based on historic portfolio performance relative to the MSCI UK Annual Healthcare Property Index.

 

The EPRA NAV provides a measure of the fair value of a company on a long-term basis. As at 30 September 2016 the EPRA NAV stated above differed from that calculated under International Financial Reporting Standards of 99.9 pence per share. This was due to the valuation of the Group's interest rate derivative contracts used to hedge its exposure to variable interest rates, which is excluded from the calculation of the EPRA NAV.

 

 

 

SUMMARY BALANCE SHEET (Unaudited)

 

 

 

 

 

 

 

 

Sept-16

Jun-16

Mar-16

Dec-15

 

 

 

 

 

£m

£m

£m

£m

 

Investment properties

 

 

232.3

210.7

184.1

167.2

 

Cash

 

 

 

42.6

65.1

23.0

41.1

 

Net current assets / (liabilities)

 

(2.1)

(1.2)

(2.0)

(3.2

 

Bank loan

 

 

 

(21.0)

(21.0)

(31.5)

(31.5)

 

Net assets

 

 

251.8

253.6

173.6

173.6

 

 

 

 

 

 

 

 

 

 

EPRA NAV per share (pence)

 

100.0

100.6

100.8

100.8

 

 

 

 

 

 

 

 

 

 

Ignores the effect of fixed/guaranteed rent reviews

 

 

 

 

 

 

The next quarterly valuation of the property portfolio will be conducted by Colliers International Healthcare LLP during December 2016 and the unaudited EPRA NAV per share as at 31 December 2016 will be announced in January 2017.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNONRNNARUAA
Date   Source Headline
28th Feb 201811:20 amRNSHolding(s) in Company
28th Feb 201810:00 amRNSDirector/PDMR Shareholding
28th Feb 20189:00 amRNSTotal Voting Rights
27th Feb 20184:37 pmRNSHolding(s) in Company
27th Feb 20183:06 pmRNSHolding(s) in Company
26th Feb 20182:42 pmRNSHolding(s) in Company
26th Feb 201810:55 amRNSHolding(s) in Company
23rd Feb 20187:00 amRNSResults of Share Issue
22nd Feb 201810:40 amRNSHolding(s) in Company
21st Feb 201812:46 pmRNSResult of General Meeting
1st Feb 20184:24 pmRNSPublication of Prospectus and Circular
1st Feb 20187:00 amRNSProposed Issue of Equity and Notice of Meeting
30th Jan 201811:44 amRNSRevolving Credit Facility
22nd Jan 20183:48 pmRNSDirectorate Change
19th Jan 20187:00 amRNSNet Asset Value, Corporate Update & Dividend
6th Dec 20177:00 amRNSAcquisitions in Hertfordshire, York and the Wirral
30th Nov 20177:00 amRNSResult of AGM
9th Nov 20177:00 amRNSNet Asset Value, Corporate Update & Dividend
3rd Nov 20177:00 amRNSNovation of Investment Management Agreement
20th Oct 20174:17 pmRNSAnnual Financial Report
4th Oct 20177:00 amRNSFinal Results
31st Aug 20177:00 amRNSNew Debt Facility
27th Jul 20177:00 amRNSCorporate Update, Net Asset Value & Dividend
12th Jul 20177:00 amRNSAcquisitions in Leicestershire and Merseyside
16th Jun 20179:58 amRNSHolding(s) in Company
26th Apr 20177:00 amRNSCorporate Update, Net Asset Value & Dividend
13th Apr 20177:00 amRNSAcquisition of three new care homes
23rd Mar 20178:11 amEQSEdison Investment Research Limited: Edison issues review on Jupiter US Smaller Companies (JUS)
22nd Mar 20174:48 pmRNSPublication of Supplementary Prospectus
22nd Mar 20178:54 amEQSEdison Investment Research Limited: Edison issues initiation on F&C Managed Portfolio Trust (FMPI; FMPG)
21st Mar 20178:50 amEQSEdison issues update on Secure Income REIT (SIR)
20th Mar 20179:09 amEQSEdison Investment Research Limited: Edison issues initiation on Target Healthcare REIT (THRL)
9th Mar 20177:00 amRNSAcquisition of two care homes in Dorset
27th Feb 20177:00 amRNSHalf-year Report
25th Jan 20177:00 amRNSCorporate Update, Net Asset Value & Dividend
14th Nov 20167:00 amRNSAcquisition of care home at Sutton-in-Ashfield
11th Nov 20167:00 amRNSResult of AGM
11th Nov 20167:00 amRNSDirectorate Change
27th Oct 20167:00 amRNSCorporate Update, Net Asset Value & Dividend
25th Oct 20167:00 amRNSAcquisition of a Care Home in Tonbridge, Kent
18th Oct 20165:05 pmRNSPublication of Supplementary Prospectus
13th Oct 20166:00 pmRNSAnnual Financial Report
29th Sep 20167:00 amRNSFinal Results
2nd Sep 20167:00 amRNSAcquisition of care home in Camberley, Surrey
2nd Sep 20167:00 amRNSExtension of Debt Facilities
30th Aug 20167:00 amRNSAcquisition of Care Homes
2nd Aug 20167:00 amRNSCorporate Update, Net Asset Value & Dividend
24th Jun 20167:00 amRNSAcquisition of care home in Cheltenham
20th Jun 20167:00 amRNSAcquisition of care home near Frinton-on-Sea,Essex
31st May 20165:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.